First Page | Document Content | |
---|---|---|
Date: 2016-12-12 15:21:52 | E-selectin Antagonist GMI-1271 Shows a Favorable Safety, PK and Bleeding Profile in Phase I Studies of Healthy Volunteers of Medicine/Division of Hematology Oncology, University of Michigan, Ann Arbor, MI;2Section of VasAdd to Reading ListSource URL: glycomimetics.comDownload Document from Source WebsiteFile Size: 1,26 MBShare Document on Facebook |